Tryptyr® (acoltremon) – New drug approval

<style type="text/css">.columns-container__full-width-background.banner__main-hero.background__main-hero {background-image: url("undefined")}@media only screen and (min-width:769px) { .columns-container__full-width-background.banner__main-hero.background__main-hero { background-image: url("undefined")}}</style>

Dynamic Alerts

Site Logo

Health care professionals website

DPL Global Search

DPL Main Nav

DPL Global Search

Breadcrumbs

Text

Tryptyr® (acoltremon) – New drug approval

May 28, 2025 - Alcon announced the FDA approval of Tryptyr (acoltremon), for the treatment of the signs and symptoms of dry eye disease (DED).

Text

Return to publications

Top